ETF Holdings Breakdown of ITOS

Stock NameIteos Therapeutics Inc
TickerITOS(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS46565G1040

News associated with ITOS

iTeos Therapeutics (NASDAQ:ITOS) vs. Molecular Partners (NASDAQ:MOLN) Head to Head Contrast
iTeos Therapeutics (NASDAQ:ITOS – Get Free Report) and Molecular Partners (NASDAQ:MOLN – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, profitability, analyst recommendations and valuation. Valuation and Earnings This table compares iTeos […] - 2025-04-30 05:48:54
Russell Investments Group Ltd. Increases Holdings in iTeos Therapeutics, Inc. (NASDAQ:ITOS)
Russell Investments Group Ltd. boosted its position in iTeos Therapeutics, Inc. (NASDAQ:ITOS – Free Report) by 115.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 57,225 shares of the company’s stock after purchasing an additional 30,619 shares during the period. Russell Investments […] - 2025-04-24 08:44:48
Renaissance Technologies LLC Grows Position in iTeos Therapeutics, Inc. (NASDAQ:ITOS)
Renaissance Technologies LLC lifted its position in iTeos Therapeutics, Inc. (NASDAQ:ITOS – Free Report) by 56.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 837,200 shares of the company’s stock after purchasing an additional 300,800 shares during the period. […] - 2025-04-20 08:00:52
Wellington Management Group LLP Raises Stake in iTeos Therapeutics, Inc. (NASDAQ:ITOS)
Wellington Management Group LLP grew its position in iTeos Therapeutics, Inc. (NASDAQ:ITOS – Free Report) by 4.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 110,332 shares of the company’s stock after purchasing an additional 4,563 shares during […] - 2025-04-14 07:50:49
KLP Kapitalforvaltning AS Invests $299,000 in iTeos Therapeutics, Inc. (NASDAQ:ITOS)
KLP Kapitalforvaltning AS bought a new stake in shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS – Free Report) in the 4th quarter, HoldingsChannel.com reports. The firm bought 38,900 shares of the company’s stock, valued at approximately $299,000. A number of other hedge funds and other institutional investors have also modified their holdings of ITOS. State Street […] - 2025-04-07 07:28:50
Raymond James Financial Inc. Makes New Investment in iTeos Therapeutics, Inc. (NASDAQ:ITOS)
Raymond James Financial Inc. bought a new position in iTeos Therapeutics, Inc. (NASDAQ:ITOS – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 150,967 shares of the company’s stock, valued at approximately $1,159,000. A number of other institutional investors have also modified their holdings of ITOS. State Street Corp raised its position […] - 2025-04-04 07:44:55
iTeos Therapeutics, Inc. (NASDAQ:ITOS) Shares Purchased by US Bancorp DE
US Bancorp DE increased its holdings in shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS – Free Report) by 40.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 16,919 shares of the company’s stock after acquiring an additional 4,843 shares during the quarter. US Bancorp DE’s […] - 2025-03-17 07:50:52
Wedbush Reaffirms “Outperform” Rating for iTeos Therapeutics (NASDAQ:ITOS)
iTeos Therapeutics (NASDAQ:ITOS – Get Free Report)‘s stock had its “outperform” rating restated by investment analysts at Wedbush in a research report issued on Wednesday,RTT News reports. They currently have a $25.00 price objective on the stock. Wedbush’s target price points to a potential upside of 252.61% from the stock’s previous close. ITOS has been […] - 2025-03-07 08:18:59
Short Interest in iTeos Therapeutics, Inc. (NASDAQ:ITOS) Increases By 5.2%
iTeos Therapeutics, Inc. (NASDAQ:ITOS – Get Free Report) was the target of a large increase in short interest in January. As of January 31st, there was short interest totalling 1,410,000 shares, an increase of 5.2% from the January 15th total of 1,340,000 shares. Based on an average trading volume of 419,500 shares, the short-interest ratio […] - 2025-02-19 08:48:54

ITOS institutional holdings

The following institutional investment holdings of ITOS have been identified

Date ETF ISIN/Name Num Shares Book value
2024-11-25 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 1,631 -299.2%USD 13,439 -303.1%
2025-05-08 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 45,362USD 303,925 3.9%
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 15,980USD 107,066
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 15,980USD 107,066 3.9%
Total =78,953 USD 531,496
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.